Duaa H. Al-Rawi

524 total citations
6 papers, 49 citations indexed

About

Duaa H. Al-Rawi is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Duaa H. Al-Rawi has authored 6 papers receiving a total of 49 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Duaa H. Al-Rawi's work include Cancer Genomics and Diagnostics (2 papers), Gestational Trophoblastic Disease Studies (2 papers) and DNA Repair Mechanisms (2 papers). Duaa H. Al-Rawi is often cited by papers focused on Cancer Genomics and Diagnostics (2 papers), Gestational Trophoblastic Disease Studies (2 papers) and DNA Repair Mechanisms (2 papers). Duaa H. Al-Rawi collaborates with scholars based in United States and Ireland. Duaa H. Al-Rawi's co-authors include Samuel F. Bakhoum, Jun Li, Emanuele Lettera, Ying Liu, Claire F. Friedman, Diana Mandelker, Roisin E. O’Cearbhaill, Maria M. Rubinstein, Raajit K. Rampal and Karen A. Cadoo and has published in prestigious journals such as Clinical Cancer Research, Nature Reviews Clinical Oncology and Current Opinion in Genetics & Development.

In The Last Decade

Duaa H. Al-Rawi

6 papers receiving 47 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duaa H. Al-Rawi United States 4 26 20 15 11 5 6 49
Apurva M. Hegde United States 4 62 2.4× 18 0.9× 15 1.0× 10 0.9× 4 0.8× 5 89
Marcel Buchholzer Germany 4 41 1.6× 21 1.1× 12 0.8× 12 1.1× 3 0.6× 7 69
Nora Diéguez-Martínez Spain 3 51 2.0× 9 0.5× 13 0.9× 11 1.0× 4 0.8× 3 64
Carmen Cañadas Spain 3 28 1.1× 8 0.4× 10 0.7× 11 1.0× 4 0.8× 6 39
Mohammad Feroze Fazaludeen Finland 4 22 0.8× 19 0.9× 9 0.6× 7 0.6× 7 1.4× 5 45
Natalya Dyakova United States 3 49 1.9× 17 0.8× 12 0.8× 10 0.9× 9 1.8× 8 71
Neus Calbet‐Llopart Spain 6 23 0.9× 31 1.6× 13 0.9× 13 1.2× 5 1.0× 11 55
Siebe Loontiens Belgium 5 19 0.7× 9 0.5× 6 0.4× 12 1.1× 2 0.4× 10 39
Aysegül Kaymak Türkiye 5 40 1.5× 9 0.5× 8 0.5× 5 0.5× 4 0.8× 8 60
Sireesha Yalavarthi United States 3 32 1.2× 29 1.4× 10 0.7× 4 0.4× 3 0.6× 9 56

Countries citing papers authored by Duaa H. Al-Rawi

Since Specialization
Citations

This map shows the geographic impact of Duaa H. Al-Rawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duaa H. Al-Rawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duaa H. Al-Rawi more than expected).

Fields of papers citing papers by Duaa H. Al-Rawi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duaa H. Al-Rawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duaa H. Al-Rawi. The network helps show where Duaa H. Al-Rawi may publish in the future.

Co-authorship network of co-authors of Duaa H. Al-Rawi

This figure shows the co-authorship network connecting the top 25 collaborators of Duaa H. Al-Rawi. A scholar is included among the top collaborators of Duaa H. Al-Rawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duaa H. Al-Rawi. Duaa H. Al-Rawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Keane, Fergus, Henry Walch, Joanne F. Chou, et al.. (2024). Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer. Clinical Cancer Research. 30(12). 2672–2683. 5 indexed citations
2.
Liu, Ying L., Sarah Chiang, Kelly A. Devereaux, et al.. (2024). Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center. Gynecologic Oncology. 192. 171–177. 1 indexed citations
3.
Al-Rawi, Duaa H., et al.. (2024). Targeting chromosomal instability in patients with cancer. Nature Reviews Clinical Oncology. 21(9). 645–659. 19 indexed citations
4.
Al-Rawi, Duaa H., Vicky Makker, Britta Weigelt, et al.. (2022). GermlineSMARCA4Deletion as a Driver of Uterine Cancer: An Atypical Presentation. JCO Precision Oncology. 6(6). e2200349–e2200349. 3 indexed citations
5.
Al-Rawi, Duaa H. & Samuel F. Bakhoum. (2022). Chromosomal instability as a source of genomic plasticity. Current Opinion in Genetics & Development. 74. 101913–101913. 16 indexed citations
6.
Al-Rawi, Duaa H., Ying Liu, Maria M. Rubinstein, et al.. (2021). Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer. Gynecologic Oncology Reports. 38. 100873–100873. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026